Full View

Ticagrelor monotherapy versus dual-antiplatelet therapy after PCI: an individual patient-level meta-analysis

M Valgimigli, R Mehran, A Franzone… - Cardiovascular …, 2021 - jacc.org
Objectives The aim of this study was to compare ticagrelor monotherapy with dual-
antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) with drug-eluting …
被引用次数：31 相关文章

[引用][C] Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis

M Valgimigli, R Mehran… - JACC …, 2021 - produccioncientifica.ucm.es

Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis

M Valgimigli, R Mehran, A Franzone… - JACC …, 2021 - iris.hunimed.eu
Objectives: The aim of this study was to compare ticagrelor monotherapy with dual-
antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) with drug-eluting …

Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis

M Valgimigli, R Mehran, A Franzone… - JACC …, 2021 - iris.unipv.it
Objectives: The aim of this study was to compare ticagrelor monotherapy with dual-
antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) with drug-eluting …

Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: an Individual Patient-Level Meta-Analysis

M Valgimigli, R Mehran, A Franzone… - JACC. Cardiovascular …, 2021 - ruj.uj.edu.pl
Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI : an Individual Patient-Level
Meta-Analysis Przejdź do treści Pomoc A A A Zmień kontrast Zaloguj English polski   …

Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis.

M Valgimigli, R Mehran, A Franzone… - JACC. Cardiovascular …, 2021 - boris.unibe.ch
OBJECTIVES The aim of this study was to compare ticagrelor monotherapy with dual-
antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) with drug-eluting …

Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis.

M Valgimigli, R Mehran, A Franzone… - JACC …, 2021 - europepmc.org
Objectives The aim of this study was to compare ticagrelor monotherapy with dual-
antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) with drug-eluting …
[HTML] sciencedirect.com

[HTML][HTML] Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis

M Valgimigli, R Mehran, A Franzone… - JACC: Cardiovascular …, 2021 - Elsevier
Objectives The aim of this study was to compare ticagrelor monotherapy with dual-
antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) with drug-eluting …

Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI An Individual Patient-Level Meta-Analysis

M Valgimigli, R Mehran, A Franzone, BR da Costa… - 2021 - documentserver.uhasselt.be
OBJECTIVES The aim of this study was to compare ticagrelor monotherapy with dual-
antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) with drug-eluting …

Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis

M Valgimigli, R Mehran, A Franzone… - JACC …, 2021 - pubmed.ncbi.nlm.nih.gov
Objectives The aim of this study was to compare ticagrelor monotherapy with dual-
antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) with drug-eluting …